The PREVENT score in hypertension, GLP-1 mechanism of action in cardiovascular disease, CAD type and statin benefit, and the problem with hospitalization endpoints in HF trials are the topics John Man...Show More
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations